Aclarion up as software shows benefit in assisting back pain surgeries

Aclarion

24/04/2023 16:23

** Shares of healthcare technology co Aclarion Inc  ACON.O 
up 178% at $2.06, a 10-month high - set to see best day in a
year if gains hold
    ** Says two-year durability data shows improved outcomes for
discogenic low back pain (DLBP) surgeries when assisted with
information from co's software Nociscan
    ** DLBP is a form of back pain associated with damaged
intervertebral discs
    ** Trials showed 22% point improvement in patients who
underwent surgery at Nociscan-identified spots vs treatments
inconsistent with Nociscan
    ** Nociscan is an augmented intelligence platform to measure
pain biomarkers in the spinal area
    ** More than 41 mln shares traded, ~2,000 times their 25-day
moving avg
    ** YTD, stock has more than tripled

 (Reporting by Aditya Samal)
 ((Aditya.Samal@thomsonreuters.com;))